What’s one of the hottest micro-cap stocks of the last three months? I’ll give you a clue: it’s a mining company that’s stock tripled in value since mid-August. But instead of mining gold, silver or platinum, this company digs something else entirely different out of the earth. Read More
Growth Investing
Just like most of the rest of the stock market, September was a surprisingly strong month for small caps. And October started out with a bang, but ended in a whimper. Together, however, it was an impressive two-month rise in stocks with market capitalizations under $2 billion,… Read More
A surging stock market has brought a smile to the face of investment bankers. They’ve suddenly found a much more receptive environment for new initial public offerings (IPOs), with 16 deals of at least $100 million being pulled off in October — the best month for IPOs this year. And… Read More
A recent article in The Economist caught my eye, and a particular statistic I found interesting was that until 1800, China and India accounted for about half of the global economy. The Industrial Revolution in the late 1700s shifted the balance of power to… Read More
It’s pretty simple really. You sell products, you bring in revenue. Subtract whatever cash was spent on those products (cost of goods sold) and you have gross profit. The larger the gross profit, the more earnings are left over once… Read More
At the end of every quarter, I like to look back over recent market laggards. Most of the stocks... Read More
At the end of every quarter, I like to look back over recent market laggards. Most of the stocks that took a recent deep hit are likely to stay depressed, but some are the victim of investor... Read More
About a week ago, a press release announced that the University of Virginia Press would be making... Read More
About a week ago, a press release announced that the University of Virginia Press would be making tens of thousands of writings and documents from the nation’s Founding Fathers available on the... Read More
In the healthcare industry, when it comes to pharmaceutical drugs, the focus is usually on the major pharmaceutical companies (like Merck (NYSE: MRK) and Johnson & Johnson (NYSE: JNJ)) that produce the drugs, and the retailers (like CVS (NYSE: CVS) and Walgreen (NYSE: WAG)) that sell them on store shelves… Read More
Microsoft (Nasdaq: MSFT) is a compelling investment. Analysts expect the software giant’s stock to return +70% to +110% during the next three or four years. Furthermore, its current price-to-earnings ratio (P/E) of 12 looks cheap next to its five-year average P/E… Read More